A randomised, double-blind, parallel group, roll-over study evaluating long-term safety and efficacy of oral doses of BI 1291583 q.d in patients with bronchiectasis(Clairleaf)

Project Details

StatusActive
Effective start/end date1/04/24 → 30/04/26

Funding

  • Boehringer Ingelheim Pty Ltd: A$144,184.00